ViewRay (NASDAQ: VRAY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.160 | -0.140 | 0.0200 | ||||
REV | 15.620M | 18.876M | 3.256M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ViewRay (NASDAQ: VRAY) through any online brokerage.
Other companies in ViewRay’s space includes: Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT), Varex Imaging (NASDAQ:VREX) and AngioDynamics (NASDAQ:ANGO).
The latest price target for ViewRay (NASDAQ: VRAY) was reported by BTIG on Friday, June 24, 2022. The analyst firm set a price target for 8.00 expecting VRAY to rise to within 12 months (a possible 185.71% upside). 5 analyst firms have reported ratings in the last year.
The stock price for ViewRay (NASDAQ: VRAY) is $2.8 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for ViewRay.
ViewRay’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for ViewRay.
ViewRay is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.